Medicare Enrolled
Dr. David Lew, M.D.
Cardiovascular Disease · Leesburg, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lew from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lew? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lew
Dr. David Lew is a cardiovascular disease in Leesburg, FL, with 20 years in practice. Based on federal Medicare data, Dr. Lew performed 19,348 Medicare services across 3,706 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lew received a total of $73,109 from 42 pharmaceutical and/or device companies across 584 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lew is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 1% volume in FL$ $73,109 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,348
Medicare services
Top 1% in FL for cardiovascular disease
3,706
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~967 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 12,305 | $0 | $1 |
| Office visit, established patient (30-39 min) | 751 | $90 | $335 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 563 | $9 | $33 |
| Regadenoson injection (Lexiscan) for heart stress test | 540 | $43 | $737 |
| Injection, heparin sodium, per 1000 units | 448 | $0 | $1 |
| Injection, midazolam hydrochloride, per 1 mg | 396 | $0 | $1 |
| Remote pacemaker/defibrillator monitoring, 90 days | 260 | $15 | $74 |
| Anticoagulant management of patient taking warfarin | 240 | $9 | $35 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 226 | $14 | $60 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 200 | $38 | $151 |
| Remote pacemaker monitoring, 90 days | 198 | $21 | $100 |
| Injection, fentanyl citrate, 0.1 mg | 197 | $1 | $2 |
| Office visit, established patient, complex (40-54 min) | 196 | $128 | $458 |
| Prothrombin time test (blood clotting) | 188 | $4 | $16 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 181 | $19 | $76 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 170 | $88 | $455 |
| Ultrasound of both sides of head and neck blood flow | 163 | $136 | $587 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 144 | $20 | $81 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 144 | $28 | $108 |
| Ultrasonic guidance for blood vessel access | 136 | $30 | $98 |
| Electrocardiogram (EKG), 12-lead | 130 | $10 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 104 | $48 | $227 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 96 | $312 | $1,198 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 85 | $319 | $1,372 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 79 | $725 | $3,740 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 79 | $134 | $604 |
| Programming of dual lead pacemaker system | 71 | $53 | $190 |
| Review by radiologist of arm or leg artery image | 65 | $116 | $462 |
| Anti-nausea injection (ondansetron/Zofran) | 64 | $0 | $1 |
| Removal of plaque and insertion of stents in arteries of leg | 63 | $7,764 | $40,825 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 62 | $26 | $183 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 61 | $76 | $440 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 61 | $0 | $1 |
| Echocardiogram, transthoracic | 46 | $133 | $636 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 45 | $2,047 | $6,671 |
| Review by radiologist of both arms or legs arteries image | 39 | $126 | $536 |
| Removal of plaque and insertion of stents in artery of leg, initial vessel | 38 | $8,933 | $38,027 |
| Injection, labetalol hydrochloride, 5 mg | 38 | $0 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 34 | $11 | $43 |
| Infusion, normal saline solution , 1000 cc | 34 | $2 | $6 |
| Cardiac catheterization | 33 | $755 | $2,980 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 32 | $498 | $2,116 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 31 | $61 | $288 |
| New patient office visit (45-59 min) | 28 | $116 | $498 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 23 | $108 | $780 |
| Ct scan of abdominal aorta and both leg arteries with contrast | 20 | $180 | $981 |
| Replacement of aortic valve through the skin and femoral artery | 18 | $617 | $4,323 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 18 | $1,543 | $4,563 |
| Shockwave destruction of calcified plaque in coronary artery accessed through skin using catheter | 17 | $131 | $867 |
| Programming of single lead pacemaker system | 16 | $47 | $166 |
| Office visit, established patient (20-29 min) | 16 | $66 | $226 |
| Coronary stent placement | 15 | $276 | $1,917 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 15 | $13 | $80 |
| Removal of plaque in artery of leg, initial vessel | 14 | $4,590 | $28,328 |
| Programming of cardiac rhythm monitor system | 14 | $42 | $138 |
| Infusion, normal saline solution, 250 cc | 14 | $1 | $2 |
| Electrocardiogram (ecg) 2-day continuous | 13 | $14 | $78 |
| Insertion of stent in groin artery, initial vessel | 12 | $1,873 | $12,653 |
| Insertion of stent in artery of leg, initial vessel | 12 | $5,367 | $24,392 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $15 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 12 | $20 | $110 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 12 | $1 | $5 |
| Insertion of stent and blood clot protection device in neck artery with review by radiologist | 11 | $733 | $3,210 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.3% high complexity
76.0% medium
18.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$73,109
Total received (2018-2024)
Avg $10,444/year across 7 years
Top 6% in FL for cardiovascular disease
42
Companies
584
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Other
Charitable contributions, space rental, and other categories
$61,080 (83.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,859 (16.2%)
Scientific / Research
Research funding and grants
$157 (0.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$56,629
2023$7,760
2022$1,846
2021$1,074
2020$1,249
2019$2,851
2018$1,700
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AngioDynamics, Inc.
$61,387
Boston Scientific Corporation
$2,363
Penumbra, Inc.
$1,652
W. L. Gore & Associates, Inc.
$1,588
Medtronic, Inc.
$1,369
Cardinal Health 200, LLC
$663
Tosoh Bioscience, Inc.
$556
Medtronic Vascular, Inc.
$505
BOSTON SCIENTIFIC CORPORATION
$386
ABIOMED
$378
Philips Electronics North America Corporation
$233
CORDIS US CORP.
$226
PFIZER INC.
$179
Edwards Lifesciences Corporation
$174
Cardinal Health 200 LLC
$167
Inari Medical, Inc.
$154
Canon Medical Systems USA, Inc.
$148
Esperion Therapeutics, Inc.
$109
SANOFI-AVENTIS U.S. LLC
$107
CVRx, Inc.
$103
Biosense Webster, Inc.
$74
Cook Medical LLC
$71
Merck Sharp & Dohme LLC
$61
Reflow Medical Inc
$53
Amgen Inc.
$50
AstraZeneca Pharmaceuticals LP
$42
Abbott Laboratories
$40
Teleflex LLC
$39
Cardiovascular Systems Inc.
$33
Arrow International, Inc.
$25
Lexicon Pharmaceuticals, Inc.
$20
Arrow Interventional, Inc.
$19
BIOTRONIK INC.
$19
Janssen Pharmaceuticals, Inc
$15
SCPHARMACEUTICALS INC.
$15
Welch Allyn
$14
E.R. Squibb & Sons, L.L.C.
$14
Novartis Pharmaceuticals Corporation
$13
Amarin Pharma Inc.
$13
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$12
GE HEALTHCARE
$11
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 89.5% of total payments
Associated products mentioned in payments ›
(1268) Allura Xper FD 20 20 · (6554) Peripheral Vascular Undivided · 2cm Peripheral Cutting Balloon · AIA-PACK · ANGIOJET · AURYON LASER SYSTEM 100-120 VAC · AVANTI Sheath Introducer · Auryon Laser System 100-120 Vac · Aviator Balloon · BRILINTA · BRITE TIP RADIANZ · Barostim Neo System · CAMZYOS · CAROTID WALLSTENT · COOK MEDICAL ZILVER PTX · COYOTE · ClosureFast · Conformable TAG Thoracic Endoprosthesis · CoreValve Evolut · Corlanor · DIREXION · Diamondback Peripheral · ELIQUIS · ELUVIA · ENTRESTO · EPIC VASCULAR · EXOSEAL · Edarbi · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · EluNIR Radaforolimus Eluting Coronary Stent System · Endurant · EverFlex · FARXIGA · FLOWTRIEVER CATHETER · FRONTRUNNER XP CTO Catheter · FUROSCIX · GENERAL ANGIOPLASTY · GENERAL ATHERECTOMY · GENERAL ANGIOPLASTY · GENERAL ATHERECTOMY · GENERAL - ATHERECTOMY · GENERAL - STRUCTURAL HEART · GENERAL ATHERECTOMY · GENERAL BALLOONS · GENERAL GUIDEWIRES · GENERAL ULTRASOUND · GORE VIABAHN Endoprosthesis with Heparin · GORE VIABAHN VBX Balloon Expandable Endo · General - Atherectomy · General - Stents · IGT D Peripheral · IGT_D Peripheral · ILAB · INNOVA · Impella · Indigo · Indigo System · Innova Vascular · Inpefa · Interventional Products · JETSTREAM · JETSTREAM SC · LUX-Dx Insertable Cardiac Monitor · LifeVest · MULTAQ · MUSTANG · MYLUX · MYNX CONTROL · MYNX CONTROLTM · MYNXGRIP · Manta · Micra · MitraClip System · Mozec Rx PTCA Balloon · MynxGrip Vascular Closure Device · NA · NEXLETOL · NanoCross · None · ONYX FRONTIER · OUTBACK LTD Re-Entry Catheter · OptiCross 35 · PRALUENT · Penumbra System · Perclose ProGlide suture mediated closure system · Protege RX · Pulsar-18 T3 · RAIDEN3T · RESOLUTE ONYX · ROTALINK · Radial Access - Other Radial Products · Ranger · Repatha · Resolute · Reveal LINQ · S · S.M.A.R.T. CONTROL Self-Expanding Nitinol Stent · S.M.A.R.T. Self-Expanding Nitinol Stent · ST AIA-PACK · STERLING · SYMPLICITY G3 · SYNERGY · Stellarex · Sterling · TSH · TSH3G · TYRX · Telescope · Trilogy 100 · Tryton Side Branch Stent · VENOUS WALLSTENT · VERQUVO · VIABAHN Endoprosthesis · VIABAHN Endoprosthesis with Heparin Bioactive Surface · VIABAHN VBX Balloon Expandable Endoprosthesis · VYNDAMAX · VYNDAQEL · Vascepa · Vein Treatment - VariLase · WALLSTENT · WATCHMAN Access System · WATCHMAN FLX · Wolverine Coronary Cutting Balloon · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 6% for cardiovascular disease in FL.
Equivalent to $378 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
53
Per 100K population
13.3
County median income
$69,956
Nearest hospital
UF HEALTH LEESBURG HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lew is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (mixed engagement, top 6%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lew experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Lew performed 12,305 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lew receive payments from pharmaceutical companies?
Yes. Dr. Lew received a total of $73,109 from 42 companies across 584 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lew's costs compare to other cardiovascular diseases in Leesburg?
Dr. Lew's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lew) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Leesburg
Browse cardiovascular diseases in Leesburg ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
AngioDynamics, Inc. Payments to Doctors
See all physicians who received payments from AngioDynamics, Inc..
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology